Healthcare provider profile · identity verified

Allison Noel Lee, NP

Nurse Practitioner · BLACKSTONE, VA · NPI 1568187581

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	827	257
Amlodipine Besylate	Amlodipine Besylate	669	210
Lisinopril	Lisinopril	445	142
Losartan Potassium	Losartan Potassium	311	97
Levothyroxine Sodium	Levothyroxine Sodium	308	91
Metformin Hcl	Metformin Hcl	269	90
Omeprazole	Omeprazole	261	90
Hydrochlorothiazide	Hydrochlorothiazide	244	86
Gabapentin	Gabapentin	221	61
Carvedilol	Carvedilol	206	54
Tamsulosin Hcl	Tamsulosin Hcl	199	64
Trazodone Hcl	Trazodone Hcl	185	47
Pantoprazole Sodium	Pantoprazole Sodium	180	61
Montelukast Sodium	Montelukast Sodium	175	60
Furosemide	Furosemide	163	51
Allopurinol	Allopurinol	160	41
Rosuvastatin Calcium	Rosuvastatin Calcium	156	58
Albuterol Sulfate Hfa	Albuterol Sulfate	150	59
Famotidine	Famotidine	135	36
Simvastatin	Simvastatin	131	43
Metoprolol Succinate	Metoprolol Succinate	129	40
Metoprolol Tartrate	Metoprolol Tartrate	125	35
Fluticasone Propionate	Fluticasone Propionate	122	44
Escitalopram Oxalate	Escitalopram Oxalate	104	36
Potassium Chloride	Potassium Chloride	98	35
Pravastatin Sodium	Pravastatin Sodium	95	29
Sertraline Hcl	Sertraline Hcl	94	33
Clopidogrel	Clopidogrel Bisulfate	88	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	85	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	85	26
Alendronate Sodium	Alendronate Sodium	83	23
Duloxetine Hcl	Duloxetine Hcl	83	27
Eliquis	Apixaban	78	26
Atenolol	Atenolol	77	27
Ezetimibe	Ezetimibe	77	23
Glipizide	Glipizide	77	24
Ozempic	Semaglutide	76	20
Alprazolam	Alprazolam	70	11
Torsemide	Torsemide	69	14
Diclofenac Sodium	Diclofenac Sodium	68	30
Clonazepam	Clonazepam	67	13
Glimepiride	Glimepiride	65	22
Glipizide Er	Glipizide	63	21
Metformin Hcl Er	Metformin Hcl	62	19
Finasteride	Finasteride	61	18
Ropinirole Hcl	Ropinirole Hcl	59	14
Spironolactone	Spironolactone	52	18
Hydroxyzine Hcl	Hydroxyzine Hcl	50	16
Januvia	Sitagliptin Phosphate	49	11
Zolpidem Tartrate	Zolpidem Tartrate	49	suppressed
Buspirone Hcl	Buspirone Hcl	48	19
Valsartan	Valsartan	48	16
Gemfibrozil	Gemfibrozil	47	suppressed
Pregabalin	Pregabalin	46	suppressed
Jardiance	Empagliflozin	44	15
Lorazepam	Lorazepam	44	11
Farxiga	Dapagliflozin Propanediol	43	11
Amiodarone Hcl	Amiodarone Hcl	42	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	42	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	14
Fluoxetine Hcl	Fluoxetine Hcl	42	11
Meloxicam	Meloxicam	42	15
Chlorthalidone	Chlorthalidone	40	18
Citalopram Hbr	Citalopram Hydrobromide	39	19
Venlafaxine Hcl Er	Venlafaxine Hcl	37	11
Levetiracetam	Levetiracetam	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	11
Lovastatin	Lovastatin	35	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	35	13
Baclofen	Baclofen	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Midodrine Hcl	Midodrine Hcl	33	suppressed
Bupropion Xl	Bupropion Hcl	32	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	31	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Meclizine Hcl	Meclizine Hcl	29	16
Amoxicillin	Amoxicillin	27	24
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Fluconazole	Fluconazole	25	19
Azithromycin	Azithromycin	24	22
Nifedipine Er	Nifedipine	24	suppressed
Rybelsus	Semaglutide	24	suppressed
Topiramate	Topiramate	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Prednisone	Prednisone	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	18
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Cephalexin	Cephalexin	19	13
Diazepam	Diazepam	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Mexiletine Hcl	Mexiletine Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Clonidine Hcl	Clonidine Hcl	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Methylprednisolone	Methylprednisolone	15	15
Ziprasidone Hcl	Ziprasidone Hcl	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Nystatin	Nystatin	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Calcium Acetate	Calcium Acetate	12	suppressed
Colchicine	Colchicine	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Otezla	Apremilast	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Indomethacin	Indomethacin	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Ramelteon	Ramelteon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error